Proprio secured $43 million in Series B funding. The capital fuels commercialization to address demand for Proprio’s AI-driven surgical navigation platform in the U.S. and overseas.
Proprio’s flagship platform, Paradigm, obtained FDA 510(k) clearance earlier this year. Paradigm is designed to harness the power of light field technology and artificial intelligence to generate a real-time 3D visualization of surgery. Paradigm provides surgeons with Volumetric Intelligence, which combines medical images with live data from Paradigm’s sensor suite.
The Paradigm system eliminates the need for intraoperative scans, reducing radiation exposure to the patient and surgical staff. By quickly registering imaging data to the anatomy within surgical workflows, Paradigm can deliver a high degree of accuracy and allow surgeons to maintain focus on the patient.
The company plans to apply its technology to many surgical specialties beyond its first targets in spine procedures.
Gabriel Jones, CEO and co-founder of Proprio, said, “This investment arrives at a pivotal moment, as we perform our first-in-human cases and bring Paradigm to patients around the world. Together, these milestones are a testament to the unparalleled capabilities of the Proprio Paradigm and its potential to revolutionize surgery.”
Proprio secured $43 million in Series B funding. The capital fuels commercialization to address demand for Proprio’s AI-driven surgical navigation platform in the U.S. and overseas.
Proprio’s flagship platform, Paradigm, obtained FDA 510(k) clearance earlier this year. Paradigm is designed to harness the power of light field technology and...
Proprio secured $43 million in Series B funding. The capital fuels commercialization to address demand for Proprio’s AI-driven surgical navigation platform in the U.S. and overseas.
Proprio’s flagship platform, Paradigm, obtained FDA 510(k) clearance earlier this year. Paradigm is designed to harness the power of light field technology and artificial intelligence to generate a real-time 3D visualization of surgery. Paradigm provides surgeons with Volumetric Intelligence, which combines medical images with live data from Paradigm’s sensor suite.
The Paradigm system eliminates the need for intraoperative scans, reducing radiation exposure to the patient and surgical staff. By quickly registering imaging data to the anatomy within surgical workflows, Paradigm can deliver a high degree of accuracy and allow surgeons to maintain focus on the patient.
The company plans to apply its technology to many surgical specialties beyond its first targets in spine procedures.
Gabriel Jones, CEO and co-founder of Proprio, said, “This investment arrives at a pivotal moment, as we perform our first-in-human cases and bring Paradigm to patients around the world. Together, these milestones are a testament to the unparalleled capabilities of the Proprio Paradigm and its potential to revolutionize surgery.”
Copy to clipboard 
